Charles River Laboratories International (CRL) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free CRL Stock Alerts $208.44 -1.28 (-0.61%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 1:26 AM | americanbankingnews.comQ2 2024 EPS Estimates for Charles River Laboratories International, Inc. Decreased by Analyst (NYSE:CRL)May 31 at 8:07 AM | marketbeat.comBrokers Set Expectations for Charles River Laboratories International, Inc.'s Q2 2024 Earnings (NYSE:CRL)Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2024 EPS estimates for shares of Charles River Laboratories International in a research note issued to investors on Thursday, May 30th. Zacks Research analyst R.May 31 at 4:44 AM | seekingalpha.comCharles River Laboratories: Fair Valuation Against FundamentalsMay 30 at 8:00 AM | businesswire.comCharles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy DevelopmentMay 30 at 7:00 AM | marketbeat.comCharles River Laboratories International Q1 Earnings TranscriptMay 30 at 5:49 AM | marketbeat.comCorient Private Wealth LLC Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Corient Private Wealth LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 114.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,358 sharesMay 28, 2024 | businesswire.comTitian Receives Multi-Year Commitment from Charles River for Mosaic Sample Management SoftwareMay 25, 2024 | marketbeat.com428,592 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Acquired by Norges BankNorges Bank purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 428,592 shares of the medical research company's stock, valued at approximately $101May 25, 2024 | americanbankingnews.comCharles River Laboratories International (NYSE:CRL) Downgraded by StockNews.com to HoldMay 25, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Cut to "Hold" at StockNews.comStockNews.com cut shares of Charles River Laboratories International from a "buy" rating to a "hold" rating in a research note on Saturday.May 24, 2024 | marketbeat.comDai ichi Life Insurance Company Ltd Trims Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Dai ichi Life Insurance Company Ltd cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 65.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,430 shares of the medicaMay 23, 2024 | marketbeat.comFranklin Resources Inc. Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Franklin Resources Inc. reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 763,015 shares of theMay 22, 2024 | marketbeat.comGW&K Investment Management LLC Increases Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)GW&K Investment Management LLC grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,510 shares ofMay 21, 2024 | marketbeat.comKing Luther Capital Management Corp Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)King Luther Capital Management Corp trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 366,834 shares of the medical research companMay 20, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Clearbridge Investments LLCClearbridge Investments LLC lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,468,059 shares ofMay 18, 2024 | marketbeat.comJackson Square Partners LLC Acquires 80,873 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Jackson Square Partners LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 349May 16, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Shares Down 4.1% Charles River Laboratories International (NYSE:CRL) Stock Price Down 4.1%May 16, 2024 | insidertrades.comJoseph W. Laplume Sells 1,304 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) StockMay 14, 2024 | marketbeat.comCuri Wealth Management LLC Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Curi Wealth Management LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,018 shares oMay 14, 2024 | marketbeat.comInsider Selling: Charles River Laboratories International, Inc. (NYSE:CRL) EVP Sells 1,304 Shares of StockCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) EVP Joseph W. Laplume sold 1,304 shares of the stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $226.97, for a total transaction of $295,968.88. Following the transaction, the executive vice president now directly owns 23,276 shares of the company's stock, valued at approximately $5,282,953.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.May 14, 2024 | gurufocus.comInsider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)May 13, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Price Target Cut to $228.00TD Cowen decreased their price target on shares of Charles River Laboratories International from $260.00 to $228.00 and set a "hold" rating on the stock in a research note on Monday.May 13, 2024 | markets.businessinsider.comCharles Rhyee Maintains Hold on Charles River Labs Amidst Revenue and Market UncertaintiesMay 12, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 21,028 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Charles Schwab Investment Management Inc. grew its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 513,227 shares of the medical researMay 11, 2024 | marketbeat.comMawer Investment Management Ltd. Buys 7,014 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Mawer Investment Management Ltd. boosted its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 36.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 26,025 shares of the medicaMay 10, 2024 | marketbeat.comTimesSquare Capital Management LLC Invests $7.53 Million in Charles River Laboratories International, Inc. (NYSE:CRL)TimesSquare Capital Management LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 31,835 shares of the medical research company's stock, valueMay 9, 2024 | markets.businessinsider.comCharles River Laboratories Reaffirms FY24 Outlook; Q1 Results Top EstimatesMay 9, 2024 | msn.comCharles River Laboratories Non-GAAP EPS of $2.27 beats by $0.21, revenue of $1.01B beats by $16.54MMay 9, 2024 | finance.yahoo.comCharles River Laboratories Announces First-Quarter 2024 ResultsMay 9, 2024 | finance.yahoo.comCharles River beats first-quarter estimates, reaffirms annual forecastMay 9, 2024 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Issues FY 2024 Earnings GuidanceCharles River Laboratories International (NYSE:CRL) updated its FY 2024 earnings guidance. The company provided EPS guidance of 10.900-11.400 for the period, compared to the consensus estimate of 11.020. The company also issued revenue guidance of $4.2 billionillion-$4.3 billionillion, compared to the consensus estimate of $4.2 billionillion.May 9, 2024 | marketbeat.comRussell Investments Group Ltd. Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Russell Investments Group Ltd. boosted its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor ownMay 8, 2024 | marketbeat.comEverpar Advisors LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Everpar Advisors LLC bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,884 shares of the medical researchMay 7, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Lowered by National Bank of Canada FINational Bank of Canada FI trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 103,774 shares of the medical research coMay 5, 2024 | marketbeat.comSapient Capital LLC Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Sapient Capital LLC bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,533 shares of the medical research company'sMay 4, 2024 | marketbeat.comRaymond James & Associates Acquires 4,660 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Raymond James & Associates lifted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor ownedMay 3, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 467,577 shares of the medical reseaMay 2, 2024 | businesswire.comCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMPMay 2, 2024 | marketbeat.comVan ECK Associates Corp Has $13.64 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company's stock after sellingMay 1, 2024 | marketbeat.comFY2024 EPS Estimates for Charles River Laboratories International, Inc. (NYSE:CRL) Boosted by AnalystCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research upped their FY2024 earnings per share estimates for Charles River Laboratories International in a report issued on Monday, April 29th. Zacks Research analyst R. Department now foApril 30, 2024 | marketbeat.comQ4 2024 EPS Estimates for Charles River Laboratories International, Inc. (NYSE:CRL) Increased by Zacks ResearchCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Analysts at Zacks Research increased their Q4 2024 earnings estimates for shares of Charles River Laboratories International in a research report issued on Monday, April 29th. Zacks Research analyst R. Department now expectApril 29, 2024 | marketbeat.comAnchor Capital Advisors LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL)Anchor Capital Advisors LLC trimmed its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,902 shares of the medicalApril 27, 2024 | marketbeat.comIFM Investors Pty Ltd Purchases New Shares in Charles River Laboratories International, Inc. (NYSE:CRL)IFM Investors Pty Ltd acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm acquired 9,586 shares of the medical research company's stock, valued at approximateApril 26, 2024 | marketbeat.comNew York State Common Retirement Fund Trims Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)New York State Common Retirement Fund trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1April 24, 2024 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 66.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 9,858 shares of the medical research compaApril 23, 2024 | barrons.comCharles River Laboratories International Inc.April 23, 2024 | morningstar.comCharles River Laboratories International IncApril 23, 2024 | marketbeat.comabrdn plc Acquires 109,275 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)abrdn plc raised its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 872.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,807 shares of the medical researchApril 22, 2024 | businesswire.comCharles River Laboratories Achieves 100% Renewable Electricity Usage GloballyApril 18, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Sells 31,134 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Raymond James Financial Services Advisors Inc. decreased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 91.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,940 shares of the medica Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Kiss of death from Joe Biden (Ad)I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care. I have uncovered a bombshell that changes everything… and threatens everything. CRL Media Mentions By Week CRL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.620.79▲Average Medical News Sentiment CRL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼105▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Medpace News Incyte News ICON Public News IQVIA News Dr. Reddy's Laboratories News Smith & Nephew News Universal Health Services News DaVita News Sarepta Therapeutics News United Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
